139 related articles for article (PubMed ID: 27483232)
1. Pro-Apoptotic Activity of New Honokiol/Triphenylmethane Analogues in B-Cell Lymphoid Malignancies.
Mędra A; Witkowska M; Majchrzak A; Cebula-Obrzut B; Bonner MY; Robak T; Arbiser JL; Smolewski P
Molecules; 2016 Jul; 21(8):. PubMed ID: 27483232
[TBL] [Abstract][Full Text] [Related]
2. Pro-apoptotic effect of an anti-CD37 scFv-Fc fusion protein, in combination with the anti-CD20 antibody, ofatumumab, on tumour cells from B-cell malignancies.
Smolewski P; Robak P; Cebula-Obrzut B; Misiewicz M; Mędra A; Majchrzak A; Witkowska M; Stromatt S; Robak T
Eur J Cancer; 2014 Oct; 50(15):2677-84. PubMed ID: 25154027
[TBL] [Abstract][Full Text] [Related]
3. The natural product honokiol induces caspase-dependent apoptosis in B-cell chronic lymphocytic leukemia (B-CLL) cells.
Battle TE; Arbiser J; Frank DA
Blood; 2005 Jul; 106(2):690-7. PubMed ID: 15802533
[TBL] [Abstract][Full Text] [Related]
4. Honokiol induces cell cycle arrest and apoptosis via inhibition of survival signals in adult T-cell leukemia.
Ishikawa C; Arbiser JL; Mori N
Biochim Biophys Acta; 2012 Jul; 1820(7):879-87. PubMed ID: 22465179
[TBL] [Abstract][Full Text] [Related]
5. Anticancer activity of Honokiol against lymphoid malignant cells via activation of ROS-JNK and attenuation of Nrf2 and NF-κB.
Gao DQ; Qian S; Ju T
J BUON; 2016; 21(3):673-9. PubMed ID: 27569089
[TBL] [Abstract][Full Text] [Related]
6. [Honokiol-induced apoptosis of human non-Hodgkin lymphoma Raji cells and its possible mechanism].
Chen W; Lin GW; Zhang Q
Nan Fang Yi Ke Da Xue Xue Bao; 2011 Nov; 31(11):1918-21. PubMed ID: 22126780
[TBL] [Abstract][Full Text] [Related]
7. Downregulation of Sp1 is involved in honokiol-induced cell cycle arrest and apoptosis in human malignant pleural mesothelioma cells.
Chae JI; Jeon YJ; Shim JH
Oncol Rep; 2013 Jun; 29(6):2318-24. PubMed ID: 23525508
[TBL] [Abstract][Full Text] [Related]
8. Honokiol Is a Potential Therapeutic Agent and Has a Synergistic Effect With 5-FU in Human Urothelial Cell Carcinoma Cells.
Lee MY; Shi CS; Hsu YC; Huang KJ; Chen SH; Zhao PW; Chung HC; Huang YC; Lee YR
Anticancer Res; 2019 Dec; 39(12):6555-6565. PubMed ID: 31810921
[TBL] [Abstract][Full Text] [Related]
9. Genistein inhibited proliferation and induced apoptosis in acute lymphoblastic leukemia, lymphoma and multiple myeloma cells in vitro.
Li W; Frame LT; Hoo KA; Li Y; D'Cunha N; Cobos E
Leuk Lymphoma; 2011 Dec; 52(12):2380-90. PubMed ID: 21749310
[TBL] [Abstract][Full Text] [Related]
10. Antineoplastic Effects of Honokiol on Melanoma.
Guillermo-Lagae R; Santha S; Thomas M; Zoelle E; Stevens J; Kaushik RS; Dwivedi C
Biomed Res Int; 2017; 2017():5496398. PubMed ID: 28194418
[TBL] [Abstract][Full Text] [Related]
11. Honokiol, a constituent of oriental medicinal herb magnolia officinalis, inhibits growth of PC-3 xenografts in vivo in association with apoptosis induction.
Hahm ER; Arlotti JA; Marynowski SW; Singh SV
Clin Cancer Res; 2008 Feb; 14(4):1248-57. PubMed ID: 18281560
[TBL] [Abstract][Full Text] [Related]
12. Honokiol induces paraptosis and apoptosis and exhibits schedule-dependent synergy in combination with imatinib in human leukemia cells.
Wang Y; Yang Z; Zhao X
Toxicol Mech Methods; 2010 Jun; 20(5):234-41. PubMed ID: 20374036
[TBL] [Abstract][Full Text] [Related]
13. Honokiol induces a necrotic cell death through the mitochondrial permeability transition pore.
Li L; Han W; Gu Y; Qiu S; Lu Q; Jin J; Luo J; Hu X
Cancer Res; 2007 May; 67(10):4894-903. PubMed ID: 17510419
[TBL] [Abstract][Full Text] [Related]
14. Honokiol induces cell cycle arrest and apoptosis via inhibiting class I histone deacetylases in acute myeloid leukemia.
Li HY; Ye HG; Chen CQ; Yin LH; Wu JB; He LC; Gao SM
J Cell Biochem; 2015 Feb; 116(2):287-98. PubMed ID: 25187418
[TBL] [Abstract][Full Text] [Related]
15. Honokiol augments the anti-cancer effects of oxaliplatin in colon cancer cells.
Hua H; Chen W; Shen L; Sheng Q; Teng L
Acta Biochim Biophys Sin (Shanghai); 2013 Sep; 45(9):773-9. PubMed ID: 23786838
[TBL] [Abstract][Full Text] [Related]
16. Anti-tumor effect of honokiol alone and in combination with other anti-cancer agents in breast cancer.
Liu H; Zang C; Emde A; Planas-Silva MD; Rosche M; Kühnl A; Schulz CO; Elstner E; Possinger K; Eucker J
Eur J Pharmacol; 2008 Sep; 591(1-3):43-51. PubMed ID: 18588872
[TBL] [Abstract][Full Text] [Related]
17. Antimetastatic activity of honokiol in osteosarcoma.
Steinmann P; Walters DK; Arlt MJ; Banke IJ; Ziegler U; Langsam B; Arbiser J; Muff R; Born W; Fuchs B
Cancer; 2012 Apr; 118(8):2117-27. PubMed ID: 21935912
[TBL] [Abstract][Full Text] [Related]
18. Synergistic antitumor effects of liposomal honokiol combined with adriamycin in breast cancer models.
Hou W; Chen L; Yang G; Zhou H; Jiang Q; Zhong Z; Hu J; Chen X; Wang X; Yuan Y; Tang M; Wen J; Wei Y
Phytother Res; 2008 Aug; 22(8):1125-32. PubMed ID: 18570244
[TBL] [Abstract][Full Text] [Related]
19. Semi-synthesis and anti-proliferative activity evaluation of novel analogues of Honokiol.
Luo Y; Xu Y; Chen L; Hu J; Peng C; Xie D; Shi J; Huang W; Xu G; Peng M; Han J; Li R; Yang S; Wei Y
Bioorg Med Chem Lett; 2009 Aug; 19(16):4702-5. PubMed ID: 19589678
[TBL] [Abstract][Full Text] [Related]
20. Honokiol, a potential therapeutic agent, induces cell cycle arrest and program cell death in vitro and in vivo in human thyroid cancer cells.
Lu CH; Chen SH; Chang YS; Liu YW; Wu JY; Lim YP; Yu HI; Lee YR
Pharmacol Res; 2017 Jan; 115():288-298. PubMed ID: 27940017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
